489 related articles for article (PubMed ID: 28192622)
1. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
[TBL] [Abstract][Full Text] [Related]
2. Baclofen for alcohol use disorder.
Minozzi S; Saulle R; Rösner S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012557. PubMed ID: 30484285
[TBL] [Abstract][Full Text] [Related]
3. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.
Garbutt JC; Kampov-Polevoy AB; Gallop R; Kalka-Juhl L; Flannery BA
Alcohol Clin Exp Res; 2010 Nov; 34(11):1849-57. PubMed ID: 20662805
[TBL] [Abstract][Full Text] [Related]
5. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
Rose AK; Jones A
Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
[TBL] [Abstract][Full Text] [Related]
6. [Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].
Krupitsky EM; Rybakova KV; Kiselev AS; Alexeeva YV; Berntsev VA; Chekhlaty EI; Zubova EY; Popov YV; Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):53-62. PubMed ID: 26356398
[TBL] [Abstract][Full Text] [Related]
7. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
[TBL] [Abstract][Full Text] [Related]
8. Moderation of baclofen response by a GABA
Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
[TBL] [Abstract][Full Text] [Related]
9. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
[TBL] [Abstract][Full Text] [Related]
10. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection.
Leggio L; Ferrulli A; Zambon A; Caputo F; Kenna GA; Swift RM; Addolorato G
Addict Behav; 2012 Apr; 37(4):561-4. PubMed ID: 22244707
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study.
Reynaud M; Aubin HJ; Trinquet F; Zakine B; Dano C; Dematteis M; Trojak B; Paille F; Detilleux M
Alcohol Alcohol; 2017 Jul; 52(4):439-446. PubMed ID: 28525555
[TBL] [Abstract][Full Text] [Related]
12. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
13. Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety.
Morley KC; Baillie A; Leung S; Addolorato G; Leggio L; Haber PS
Alcohol Alcohol; 2014 Nov; 49(6):654-60. PubMed ID: 25246489
[TBL] [Abstract][Full Text] [Related]
14. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
[TBL] [Abstract][Full Text] [Related]
15. Effect of High-Dose Baclofen on Agitation-Related Events Among Patients With Unhealthy Alcohol Use Receiving Mechanical Ventilation: A Randomized Clinical Trial.
Vourc'h M; Garret C; Gacouin A; Lacherade JC; Jonas M; Klouche K; Ferrandiere M; Jaber S; Flet L; Dailly E; Pouplet C; Maamar A; Reignier J; Roquilly A; Feuillet F; Mahe PJ; Asehnoune K;
JAMA; 2021 Feb; 325(8):732-741. PubMed ID: 33620407
[TBL] [Abstract][Full Text] [Related]
16. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
Morley KC; Baillie A; Fraser I; Furneaux-Bate A; Dore G; Roberts M; Abdalla A; Phung N; Haber PS
Br J Psychiatry; 2018 Jun; 212(6):362-369. PubMed ID: 29716670
[TBL] [Abstract][Full Text] [Related]
17. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial.
Dieperink E; Fuller B; Isenhart C; McMaken K; Lenox R; Pocha C; Thuras P; Hauser P
Addiction; 2014 Nov; 109(11):1869-77. PubMed ID: 25040898
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Vonghia L; Mirijello A; Abenavoli L; D'Angelo C; Caputo F; Zambon A; Haber PS; Gasbarrini G
Lancet; 2007 Dec; 370(9603):1915-22. PubMed ID: 18068515
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
Morley KC; Leung S; Baillie A; Haber PS
Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
